Anteris Technologies

Last updated

Anteris Technologies Limited
Formerly
  • Allied Healthcare Group (2011–2013)
  • Admedus (2013–2020)
Company type Public
ASX:  AVR
IndustryBiotechnology
Headquarters
Toowong
,
Australia
Website anteristech.com

Anteris Technologies Limited is an Australian biotechnology company.

Contents

History

Anteris originates from the merger of Allied Medical and BioMD. Allied Medical was a company spun out of mining company Fortescue in 2005 which focused on selling medical equipment such as catheters. [1] It entered the biotechnology space in July 2010 when it purchased a 38.6 per cent stake in Brisbane-based Coridon for A$3 million. [2] By February 2011, its stake increased to 55 per cent. [3] In February 2011, Allied Medical agreed to a reverse takeover deal with BioMD, a listed biotech company. [3] The takeover was completed in June 2011 resulting in the combined company, Allied Healthcare Group, listing on the Australian Securities Exchange (ASX). [4] [5] [6]

In September 2012, Allied raised $10.4 million to launch CardioCel across Europe. [7] In November 2013, Allied Healthcare changed its name to Admedus. [8] In December 2013, Admedus purchased a manufacturing site in Malaga to scale-up production of CardioCel and support the development and manufacture of additional regenerative tissue products. [7]

In October 2019, Admedus sold its CardioCel and VascuCel patch business to U.S.-based LeMaitre Vascular. [9] Under the agreement, Admedus received A$22.8 million upfront followed by deferred payments of $1 million each at 12 months and at 36 months. Additionally, the company could receive up to $11.4 million in earn-out payments. [10] Admedus retained the right to manufacture CardioCel and VascuCel products at its Malaga facility for LeMaitre over the following three years. [9] In May 2020, Admedus changed its name to Anteris Technologies. [11]

References

  1. ↑ Thomson, James (18 July 2010). "Medical company backed by mining billionaire Andrew Forrest launches biotech investment push". SmartCompany. Retrieved 14 March 2023.
  2. ↑ Greenblat, Eli (18 July 2010). "Mining magnate invests in biotech". Sydney Morning Herald . Retrieved 15 March 2023.
  3. 1 2 Evans, Nick (15 February 2011). "Forrest biotech company to list". PerthNow . Retrieved 15 March 2023.
  4. ↑ Evans, Nick (31 May 2011). "BioMD's Allied takeover wrapping up soon". PerthNow. Retrieved 15 March 2023.
  5. ↑ Stafford, Patrick (20 June 2011). "Andrew Forrest-backed biotech lists on ASX". SmartCompany. Archived from the original on 24 June 2011. Retrieved 15 March 2023.
  6. ↑ "bioMD Limited Makes Offer for Unlisted Allied Medical to Create Diversified Healthcare Group" (Press release). BioSpace. 15 February 2011. Retrieved 16 March 2023.
  7. 1 2 Drummond, Cameron (12 December 2013). "Biotech company buys manufacturing facility". Business News . Retrieved 15 March 2023.
  8. ↑ Smith, Sean (21 November 2013). "Allied rebrands as Admedus". The West Australian . Retrieved 15 March 2023.
  9. 1 2 "Admedus sells its CardioCel and VascuCel patch business for $A36.2m". Australian Manufacturing. 16 October 2019. Retrieved 15 March 2023.
  10. ↑ Ford, Omar (14 October 2019). "Admedus Turns Attention to TAVR Program". mddionline.com. Retrieved 15 March 2023.
  11. ↑ Anderson, Caitlin (21 February 2023). "Med-device company Anteris Technologies raises $24 million". www.bizjournals.com. Retrieved 8 August 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.